General Information of the Compound
Compound ID
CP0509610
Compound Name
(S)-2-(4-(3-chlorophenyl)piperazin-1-yl)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid
    Show/Hide
Structure
Formula
C31H32ClN3O4
Molecular Weight
546.067
Canonical SMILES
Cc1oc(nc1CCOc1ccc(C[C@H](N2CCN(CC2)c2cccc(Cl)c2)C(O)=O)cc1)-c1ccccc1
    Show/Hide
InChI
InChI=1S/C31H32ClN3O4/c1-22-28(33-30(39-22)24-6-3-2-4-7-24)14-19-38-27-12-10-23(11-13-27)20-29(31(36)37)35-17-15-34(16-18-35)26-9-5-8-25(32)21-26/h2-13,21,29H,14-20H2,1H3,(H,36,37)/t29-/m0/s1
    Show/Hide
InChIKey
YINHHOIJNKUMLH-LJAQVGFWSA-N
Physicochemical Property
logP
5.74282
Rotatable Bonds
10
Heavy Atom Count
39
Polar Areas
79.04
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
39

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11570226
SID: 16672463
ChEMBL ID
CHEMBL1090861
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00910, Peroxisome proliferator-activated receptor alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
Protein ID: PT00915, Peroxisome proliferator-activated receptor gamma
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 45230 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000293 HLF Homo sapiens (Human)  1
1
IC50 = 44400 nM
   TI
   LI
   LO
   TS